Filter
455
Text search:
food
labelling
Featured
Recommendations
43
New Publications
100
Language
Document type
No document type
187
Studies & Reports
106
Guidelines
87
Manuals
35
Strategic & Response Plan
27
Training Material
5
Fact sheets
4
Brochures
2
Dashboards/Maps
1
Situation Updates
1
Countries / Regions
Global
28
India
21
Kenya
15
Ghana
12
Tanzania
10
Zambia
9
South Africa
9
Ethiopia
7
Uganda
7
Western and Central Europe
7
Nigeria
5
Namibia
5
Zimbabwe
4
Syria
4
Malawi
4
South–East Asia Region
4
Nepal
3
Moldova
3
Kyrgyzstan
3
Sierra Leone
2
Liberia
2
Congo, Democratic Republic of
2
Philippines
2
Rwanda
2
Botswana
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
Western Pacific Region
2
Africa
2
Eastern Europe
2
Kazakhstan
2
Bosnia and Herzegovina
2
Senegal
1
Mali
1
USA
1
Pakistan
1
Turkey
1
Cambodia
1
Thailand
1
Gambia
1
China
1
Peru
1
Myanmar / Burma
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Venezuela
1
Southern Africa
1
Canada
1
Tajikistan
1
Vietnam
1
Turkmenistan
1
United Kingdom
1
Portugal
1
Spain
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
143
Public Health
52
Key Resources
36
Clinical Guidelines
34
Women & Child Health
28
Pharmacy & Technologies
19
Capacity Building
9
Toolboxes
Pharmacy
34
Planetary Health
33
AMR
30
NCDs
26
Mental Health
22
COVID-19
19
Disability
13
Ebola & Marburg
12
NTDs
11
Rapid Response
10
HIV
10
Specific Hazards
10
Global Health Education
10
Refugee
9
Caregiver
9
TB
8
Conflict
7
Malaria
6
2.0 Rapid Response
4
Cholera
3
Polio
2
Zika
2
Social Ethics
2
The procurement of essential medicines and other health products is a critical function in support of the effective discharge of WHO’s mandate, and WHO values the importance of the quality of essential medicines and health products that are supplied to countries. The first World Health Assembly in
...
Annex 5, WHO Technical Report Series 1010, 2018
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp
...
This section provides general information on HCW and key elements of management procedures that are essential to know before developing a HCWM plan.
The Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014–2020) was developed in response to a resolution adopted at the sixty-second session of the WHO Regional Committee for the Western Pacific. The regional plan is fully harmonized with
...
There is an expanding market of no- and low-alcohol beverages (NoLos). However, their effects on global ethanol consumption and public health are still questioned. Policies and regulations about NoLos’ availability, acceptability and affordability are lacking and evidence about their benefits is l
...
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term
...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for
...
"This Code provides practical guidance on how to manage health and safety risks associated with hazardous
chemicals for persons conducting a business or undertaking who use chemicals in their workplace."
This document has been developed as a guide to allinstitutions producing health care waste in planning and implementation of interventions that will reduce mismanagement of hazardous waste in Zambia.The National Health-Care Waste Management Plan for 2015 to 2019 provides an overv
...
The WHO Framework for the clinical evaluation of devices for male circumcision
outlines a multi-phase process to ensure the safety, efficacy, and acceptability of new devices, especially for use in resource-limited settings
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,
...